B Vitamins and Homocysteine: The Brain-Shrinkage Trials Explained

What homocysteine is

Homocysteine is an amino acid made when your body processes methionine, which comes from protein. Normally it's quickly converted into other compounds — and that conversion depends on folate, vitamin B12, and vitamin B6. When any of those run low, homocysteine accumulates in the blood. Kidney function, some medications, and genetic variants also influence levels.

That makes homocysteine a useful functional marker. NIH's Office of Dietary Supplements notes that homocysteine rises as B12 status declines, and that a level above 15 micromol/L may suggest B12 deficiency — though the marker isn't specific, because folate and kidney function also affect it.^[2]

The observational link to dementia

Many observational studies link high homocysteine to Alzheimer's disease and dementia. ODS summarizes that most observational studies show this association, while most trials have not shown that folic acid supplementation affects cognition or dementia risk.^[1]

That gap is the whole story in miniature. An association doesn't tell you whether homocysteine causes harm, merely marks it, or reflects something else (like poor diet or kidney disease). Only trials can test whether lowering it helps.

VITACOG: the brain-shrinkage trial

The trial that put B vitamins on the brain-health map was VITACOG, run by researchers at Oxford and published in PLoS ONE in 2010.^[3]

• Who: 271 adults over 70 with mild cognitive impairment; 168 completed the MRI sub-study.
• What: folic acid 0.8 mg, vitamin B12 0.5 mg, and vitamin B6 20 mg daily, or placebo.
• How long: 24 months.

The authors concluded that homocysteine-lowering B vitamins slowed accelerated brain atrophy in MCI. Just as important are the limitations they stated: the trial was small, not powered to detect cognitive effects, and the subgroup findings need confirmation. They called for trials testing whether treatment delays progression to Alzheimer's disease.^[3]

Why most other trials were disappointing

When researchers tested B vitamins in broader populations, the results were mostly flat. ODS lists several:^[1]

• A Netherlands trial in 195 adults aged 70+ (folic acid 400 mcg plus B12 1 mg for 24 weeks) lowered homocysteine by 36% but didn't improve cognition.
• A trial of 5,000 mcg folic acid for 18 months in 340 people with Alzheimer's didn't slow decline.
• A meta-analysis of 11 trials in more than 20,000 older adults found that B vitamins lowered homocysteine but did not affect cognitive aging or global cognition.

But there were signals in specific groups. In the Women's Antioxidant and Folic Acid Cardiovascular Study, B vitamins didn't change average cognition, but they slowed cognitive decline in women with low baseline dietary B-vitamin intake. And a Netherlands trial in 818 adults aged 50–70 with homocysteine of at least 13 µmol/L found that 800 mcg folic acid for 3 years improved global cognition, memory, and processing speed.^[1]

Put together, the pattern is consistent: little benefit for people whose levels are already fine, and possible benefit for people who are low or have elevated homocysteine. Our DHA and cognitive decline explainer describes a similar "baseline status matters" theme for omega-3s.

Who should get tested first

Because the benefit appears tied to elevated homocysteine or low B-vitamin status, testing comes before supplementing. It's especially worth discussing with your clinician if you:

• Are over 65, or have memory complaints or a diagnosis of mild cognitive impairment.
• Take metformin or acid-reducing drugs (PPIs or H2 blockers), which can lower B12.^[2]
• Eat a vegan or largely plant-based diet (B12 risk).
• Have alcohol use disorder, inflammatory bowel disease, or a history of gastric surgery (folate and B12 risk).
• Take methotrexate, sulfasalazine, or certain anti-seizure drugs, which interact with folate.^[1]
• Have kidney disease, which can raise homocysteine independently.

Useful tests may include serum B12, folate, homocysteine, and sometimes methylmalonic acid. Your clinician can interpret them together.

Safety: folic acid isn't free

• Upper limit: the tolerable upper intake level for adults is 1,000 mcg/day of folic acid from supplements and fortified foods, unless you're under medical supervision.^[1]
• B12 interplay: large folate doses can correct the anemia of B12 deficiency without fixing the neurological damage, and researchers have raised concerns that high folate may worsen B12-related problems. Don't take high-dose folic acid without knowing your B12 status.^[1]
• Methylfolate: ODS notes 5-MTHF's bioavailability is the same as or greater than folic acid. Evidence that people with MTHFR variants benefit from it specifically is inconclusive.^[1]
• B6: long-term high-dose B6 can cause nerve problems; stick to labeled doses and your clinician's advice.
• Heart disease: ODS notes that lowering homocysteine with supplements hasn't reduced cardiovascular disease risk.^[2]